Clinical Trial Update: Atheroma Progression and Vulnerability Under Continuous Glucose Monitoring [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating atheroma progression and vulnerability under continuous glucose monitoring in coronary atherosclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Atherosclerosis

Snippet

Sponsor: National Cerebral and Cardiovascular Center, Japan | Conditions: Coronary Atherosclerosis | Phase 4 | Status: UNKNOWN